These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Novel Potent and Selective Acetylcholinesterase Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease: Synthesis, Pharmacological Evaluation, and Molecular Modeling of Amino-Alkyl-Substituted Fluoro-Chalcones Derivatives. Liu HR; Zhou C; Fan HQ; Tang JJ; Liu LB; Gao XH; Wang QA; Liu WK Chem Biol Drug Des; 2015 Oct; 86(4):517-22. PubMed ID: 25588967 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase. Ceyhun İ; Karaca Ş; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100372. PubMed ID: 34893996 [TBL] [Abstract][Full Text] [Related]
6. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones. Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and Molecular Docking of New Bis-Thiazolidinone-Based Chalcone Analogs as Effective Inhibitors of Acetylcholinesterase and Butyrylcholinesterase. Hussain R; Rahim F; Rehman W; Taha M; Khan S; Zaman K; Adnan Ali Shah S; Wadood A; Imran S; Abdellatif MH Chem Biodivers; 2022 Oct; 19(10):e202200323. PubMed ID: 35997224 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, biological evaluation and molecular docking of cyclic biguanidine compounds as cholinesterase inhibitors. Gungor O; Kose M J Biomol Struct Dyn; 2023 Dec; 41(20):10885-10899. PubMed ID: 36537267 [TBL] [Abstract][Full Text] [Related]
9. Ultrasound-assisted synthesis of novel chalcone, heterochalcone and bis-chalcone derivatives and the evaluation of their antioxidant properties and as acetylcholinesterase inhibitors. Polo E; Ibarra-Arellano N; Prent-Peñaloza L; Morales-Bayuelo A; Henao J; Galdámez A; Gutiérrez M Bioorg Chem; 2019 Sep; 90():103034. PubMed ID: 31280015 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors. Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors. Liu HR; Liu XJ; Fan HQ; Tang JJ; Gao XH; Liu WK Bioorg Med Chem; 2014 Nov; 22(21):6124-33. PubMed ID: 25260958 [TBL] [Abstract][Full Text] [Related]
12. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease. Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship investigation of coumarin-chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors. Kang L; Gao XH; Liu HR; Men X; Wu HN; Cui PW; Oldfield E; Yan JY Mol Divers; 2018 Nov; 22(4):893-906. PubMed ID: 29934672 [TBL] [Abstract][Full Text] [Related]
14. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents. Pandey S; Singh BK Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255 [TBL] [Abstract][Full Text] [Related]
15. Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease. Bajad NG; Singh RB; T A G; Gutti G; Kumar A; Krishnamurthy S; Singh SK Bioorg Chem; 2024 Feb; 143():107082. PubMed ID: 38199142 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological activities, and evaluation of molecular docking-dynamics studies of new thiosemicarbazones that may be effective against Alzheimer's disease. Conger N; Osmaniye D; Sağlık BN; Levent S; Ozkay Y; Kaplancıklı ZA J Mol Recognit; 2023 Dec; 36(12):e3059. PubMed ID: 37723924 [TBL] [Abstract][Full Text] [Related]
17. Exploring enzyme inhibition profiles of novel halogenated chalcone derivatives on some metabolic enzymes: Synthesis, characterization and molecular modeling studies. Anil DA; Polat MF; Saglamtas R; Tarikogullari AH; Alagoz MA; Gulcin I; Algul O; Burmaoglu S Comput Biol Chem; 2022 Oct; 100():107748. PubMed ID: 35917597 [TBL] [Abstract][Full Text] [Related]
18. Chalcone Scaffolds Exhibiting Acetylcholinesterase Enzyme Inhibition: Mechanistic and Computational Investigations. Malik YA; Awad TA; Abdalla M; Yagi S; Alhazmi HA; Ahsan W; Albratty M; Najmi A; Muhammad S; Khalid A Molecules; 2022 May; 27(10):. PubMed ID: 35630658 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease. Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of bakuchiol derivatives as multi-target agents for the treatment of Alzheimer's disease. Zhang XQ; Xiang YN; Qin T; Zou JP; Guo QW; Han ST; Zhang ZY; Liu WW; Ding G; Dong JQ; Shi DH Fitoterapia; 2024 Apr; 174():105867. PubMed ID: 38382891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]